Islets in Type 2 Diabetes: In Honor of Dr. Robert C. Turner
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
The UK Prospective Diabetes Study (UKPDS) orchestrated by Robert Turner showed that, even with treatment, in type 2 diabetes a progressive β-cell dysfunction in a large number of patients was seen with the eventual need for additional oral antihyperglycemic medication and even insulin treatment (1). Such a progression could be from a continued loss of β-cells, a progressive functional change, or from the combination of both. During the decades when type 2 diabetes was considered mainly a disease of insulin resistance, many older pathology studies that focused on the islets in diabetic pancreata were ignored. However, with the renewed appreciation of the role of the pancreatic β-cell in type 2 diabetes, new studies have focused on what happens to the β-cells in type 2 diabetes. This perspectives in diabetes article will present what we know and still need to know about the islets in type 2 diabetes. ### Islet architecture in human pancreas. The islets of most mammalian species have a nonrandom pattern with a core of β-cells surrounded by a discontinuous mantle of non-β-cells one to three cells thick (2,3). However, islets of human and other primates have a more complex arrangement with many different islet profiles, including cloverleaf patterns. The profile differences have led to controversy about whether they actually have a mantle-core arrangement (3) or were random (4–6). In three dimensions, human islets can be considered as composites of several mantle-core subunits (7) or as lobulated with mantle-core lobules (3). In smaller islets, the rodent mantle core subunit arrangement is maintained, but in larger islets irregular fusion of such subunits are seen (Fig. 1). Most of the non-β-cells are found along penetrations of islet vasculature between subunits and the periphery (3,4), thus maintaining a mantle-core arrangement. Histologically, islets in the type 2 diabetic pancreas do not appear …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“β-Cell mass in T2D likewise varies, overlapping with that of normal individuals ( 55 – 57 ), although current data suggest a 20–60% reduction ( 58 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [56]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Self-citationInclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979 · cited 1×
“It was recently shown that the fibrillar inclusions formed by mutant huntingtin in Huntington’s disease neurons were protective rather than detrimental to the cells in which they occurred (50).”
BackgroundThe unique cytoarchitecture of human pancreatic islets has implications for islet cell function
Cabrera, O., Berman, D. M., Kenyon, N. S., Ricordi, C., Berggren, P.-O., & Caicedo, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510790103 · Cited by 1,312 · cited 1×
“However, in studies using laser-scanning confocal microscopy on fewer islets, the -cell number in islets was estimated to be 55% (2–5 islets/section, 5 pancreata) (5) or 53.”
BackgroundCooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299
Westermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T. D., & Johnson, K. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3881 · Cited by 976 · cited 2×
“In pursuit of this clue to the pathogenesis of type 2 diabetes, two independent groups (including Robert Turner’s) reported the amino acid sequence of human IAPP (amylin) in 1987 (28,29), and since then enormous strides have been made in the understanding of the pathogenesis of islet amyloidosis and its potential role…”
BackgroundSelf-citationPancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
Lorenzo, A., Razzaboni, B., Weir, G. C., & Yankner, B. A. (1994) · Nature · doi:10.1038/368756a0 · Cited by 820 · cited 3×
“While mature amyloid fibrils were initially thought to be the likely mediators of hIAPP toxicity, it has become increasingly apparent that it is actually the relatively small soluble oligomers of hIAPP that are most toxic to -cells (26,33).”
BackgroundBrissova, M., Fowler, M. J., Nicholson, W. E., Chu, A., Hirshberg, B., Harlan, D. M., & Powers, A. C. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5c6684.2005 · Cited by 797 · cited 1×
“5% (32 islets isolated from 6 pancreata) (6).”
Sakuraba, H., Mizukami, H., Yagihashi, N., Wada, R., Hanyu, C., & Yagihashi, S. (2002) · Diabetologia · doi:10.1007/s125-002-8248-z · Cited by 681 · cited 3×
“(12) found no evidence of apoptosis in either diabetic or nondiabetic individuals.”
BackgroundResultSelective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea
Yoon, K. H., Ko, S. H., Cho, J. H., Lee, J. M., Ahn, Y. B., Song, K. H., Yoo, S. J., Kang, M. I., Cha, B. Y., Lee, K. W., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020735 · Cited by 649 · cited 3×
“(15) showed a linear relation between body weight and -cell mass in a Korean population.”
BackgroundResultSelf-citationJanson, J., Ashley, R. H., Harrison, D., McIntyre, S., & Butler, P. C. (1999) · Diabetes · doi:10.2337/diabetes.48.3.491 · Cited by 612 · cited 2×
“While mature amyloid fibrils were initially thought to be the likely mediators of hIAPP toxicity, it has become increasingly apparent that it is actually the relatively small soluble oligomers of hIAPP that are most toxic to -cells (26,33).”
BackgroundIslet Pathology and the Pathogenesis of Type 1 and Type 2 Diabetes mellitus Revisited
Klöppel, G., Löhr, M., Habich, K., Oberholzer, M., & Heitz, P. U. (1985) · Pathology and Immunopathology Research · doi:10.1159/000156969 · Cited by 577 · cited 3×
“However, it was not until 1985 that increased -cell mass in nondiabetic obese people was clearly shown, albeit with a low number of pancreata (13).”
BackgroundInfluentialJonas, J.-C., Sharma, A., Hasenkamp, W., Ilkova, H., Patanè, G., Laybutt, R., Bonner-Weir, S., & Weir, G. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.14112 · Cited by 559 · cited 1×
“cannot be progressive functional changes in human -cells, as seen in rodents with chronic hyperglycemia (24).”
BackgroundSelf-citationMark, R. J., Pang, Z., Geddes, J. W., Uchida, K., & Mattson, M. P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-03-01046.1997 · Cited by 551 · cited 1×
“Of special interest is the finding that membrane lipid peroxidation initiated by A is also associated with impaired glucose transport into cultured rat hippocampal neurons (36).”
BackgroundSaisho, Y., Butler, A. E., Meier, J. J., Monchamp, T., Allen‐Auerbach, M., Rizza, R. A., & Butler, P. C. (2007) · Clinical Anatomy · doi:10.1002/ca.20543 · Cited by 479
Endoplasmic Reticulum Stress and the Development of Diabetes
Harding, H. P., & Ron, D. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s455 · Cited by 465 · cited 1×
“-cells, like other “professional” secretory cells, are known to be particularly sensitive to perturbations of ER function that may lead to misfolded proteins (47).”
BackgroundPore Formation by the Cytotoxic Islet Amyloid Peptide Amylin
Mirzabekov, T. A., Lin, M.-C., & Kagan, B. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1988 · Cited by 442 · cited 1×
“Other studies have demonstrated that nonselective ion-permeable membrane pores form upon exposure to hIAPP oligomers (31).”
BackgroundHuang, C.-J., Lin, C.-Y., Haataja, L., Gurlo, T., Butler, A. E., Rizza, R. A., & Butler, P. C. (2007) · Diabetes · doi:10.2337/db07-0197 · Cited by 416 · cited 1×
“Precisely such responses, which included upregulation of C/EBP homologous protein (CHOP) expression followed by nuclear translocation and apoptosis, were demonstrated recently in INS-1 cells induced to express hIAPP (48).”
BackgroundFUNCTIONAL SUBDIVISION OF ISLETS OF LANGERHANS AND POSSIBLE ROLE OF D CELLS
Orci, L., & Unger, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92078-4 · Cited by 414 · cited 1×
“The islets of most mammalian species have a nonrandom pattern with a core of -cells surrounded by a discontinuous mantle of non- -cells one to three cells thick (2,3).”
BackgroundCellular composition of the human diabetic pancreas
Rahier, J., Goebbels, R. M., & Henquin, J. C. (1983) · Diabetologia · doi:10.1007/bf00251826 · Cited by 395 · cited 2×
“1); there are occasional large islets seen with a majority of glucagonpositive cells (11,15), and islets from the pancreatic polypeptide (PP)-rich uncinate process are mainly PP cells, with -cells being only 32.”
BackgroundIslet growth and development in the adult
Bonner-Weir, S. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0240297 · Cited by 331 · cited 1×
“In rodents it has been clear that there is a compensatory increase in -cell mass in response to insulin resistance or obesity (20), so we assume a similar increase in humans is compensatory.”
BackgroundSelf-citationEffects of Meal Ingestion on Plasma Amylin Concentration in NIDDM and Nondiabetic Humans
Butler, P. C., Chou, J., Carter, W. B., Wang, Y.-N., Bu, B.-H., Chang, D., Chang, J.-K., & Rizza, R. A. (1990) · Diabetes · doi:10.2337/diab.39.6.752 · Cited by 330 · cited 1×
“IAPP was shown to be copackaged and cosecreted with insulin as a normal product of the -cell (28,30).”
BackgroundThe U.K. Prospective Diabetes Study. A review
Turner, R. C. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.c35 · Cited by 267 · cited 1×
“The UK Prospective Diabetes Study (UKPDS) orchestrated by Robert Turner showed that, even with treatment, in type 2 diabetes a progressive -cell dysfunction in a large number of patients was seen with the eventual need for additional oral antihyperglycemic medication and even insulin treatment (1).”
BackgroundQuantitative Estimation of the Pancreatic Islet Tissue in Diabetic Subjects
Maclean, N., & Ogilvie, R. F. (1955) · Diabetes · doi:10.2337/diab.4.5.367 · Cited by 248 · cited 4×
“Older studies such as that by Maclean and Ogilvie (17) showed decreased -cell mass in diabetes but did not distinguish between type 1 and type 2 diabetes, even though the age at onset roughly categorizes their cases.”
BackgroundResultInfluentialThe islands of langerhans in 19 cases of obesity
Ogilvie, R. F. (1933) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700370314 · Cited by 244 · cited 1×
“As early as 1933, it was suggested that many obese individuals had abnormally high islet volume density (number of islets per area) (19).”
BackgroundNATIVE KIDNEYS IN POST-TRANSPLANTATION HYPERTENSION
Van Ypersele De Strihou, C. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90769-x · Cited by 229
Islet Amyloid, Islet-Amyloid Polypeptide, and Diabetes Mellitus
Epstein, F. H., Johnson, K. H., O'Brien, T. D., Betsholtz, C., & Westermark, P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908243210806 · Cited by 205
Self-citationMattson, M. P., & Goodman, Y. (1995) · Brain Research · doi:10.1016/0006-8993(95)00148-j · Cited by 190
Erlandsen, S. L., Hegre, O. D., Parsons, J. A., McEvoy, R. C., & Elde, R. P. (1976) · Journal of Histochemistry & Cytochemistry · doi:10.1177/24.7.60437 · Cited by 185
Lin, C.-Y., Gurlo, T., Kayed, R., Butler, A. E., Haataja, L., Glabe, C. G., & Butler, P. C. (2007) · Diabetes · doi:10.2337/db06-1579 · Cited by 183 · cited 1×
“In addition, antibodies obtained against this marker for the toxic epitope have allowed examination of the presence and location of these oligomers in hIAPP-transgenic mouse models of type 2 diabetes (39).”
BackgroundBrender, J., Dürr, U., Heyl, D., Budarapu, M. B., & Ramamoorthy, A. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.07.001 · Cited by 141 · cited 1×
“Several studies have now shown that prefibrillar oligomers act by disrupting lipid bilayers and can lead to membrane fragmentation (37).”
BackgroundLongitudinal studies on the development of diabetes in individual Macaca nigra
Howard, C. F. (1986) · Diabetologia · doi:10.1007/bf00452067 · Cited by 141 · cited 2×
“In an elegant longitudinal study of Macaca nigra, Howard evaluated -cell function and, using serial pancreatic biopsies, evaluated islet morphology, including IA formation (49).”
BackgroundMethodIslet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide.
Soeller, W. C., Janson, J., Hart, S. E., Parker, J. C., Carty, M. D., Stevenson, R. W., Kreutter, D. K., & Butler, P. C. (1998) · Diabetes · doi:10.2337/diabetes.47.5.743 · Cited by 140
Saito, K., Yaginuma, N., & TAKAHASHI, T. (1979) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.129.273 · Cited by 138 · cited 1×
“37 nondiabetic pancreata) (23); another reported 62.”
Decreased insulin secretion in type 2 diabetes: a problem of cellular mass or function?
Clark, A., Jones, L. C., de Koning, E. J. P., HANSEN, B. C., & Matthews, D. R. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s169 · Cited by 121 · cited 1×
“While several groups have maintained there is no significant decrease in -cell mass in type 2 diabetes (11,14,21,22), most studies have shown a 40–60% decrease, particularly compared with pancreata from nondiabetic individuals of similar body weight or BMI.”
BackgroundZhang, S., Liu, J., Dragunow, M., & Cooper, G. J. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308244200 · Cited by 118
Hull, R. L., Andrikopoulos, S., Verchere, C. B., Vidal, J., Wang, F., Cnop, M., Prigeon, R. L., & Kahn, S. E. (2003) · Diabetes · doi:10.2337/diabetes.52.2.372 · Cited by 118
Replication Increases β-Cell Vulnerability to Human Islet Amyloid Polypeptide-Induced Apoptosis
Ritzel, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1701 · Cited by 115 · cited 1×
“In support of this hypothesis, it has been found that RIN and HeLa cells, when exposed to hIAPP toxic oligomers, had increased apoptosis within 3 h of mitosis (51).”
BackgroundO'Brien, T. D., Westermark, P., & Johnson, K. H. (1991) · Diabetes · doi:10.2337/diab.40.12.1701 · Cited by 108 · cited 2×
“Although insulin and IAPP tend to be regulated in parallel, such as their upregulation in insulin resistance, significant divergence from this parallel expression may occur under some physiologic or pathologic conditions that may play roles in amyloidogenesis (43).”
BackgroundSelf-citationEffects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans
Butler, P. C., Chou, J., Carter, W. B., et al. (1990) · Diabetes · doi:10.2337/diabetes.39.6.752 · Cited by 94
Couce, M., Kane, L. A., O’Brien, T. D., Charlesworth, J. E., Soeller, W. C., McNeish, J. D., Kreutter, D. K., Roche, P. C., & Butler, P. C. (1996) · Diabetes · doi:10.2337/diab.45.8.1094 · Cited by 91
Self-citationCosecretion of amylin and insulin from isolated rat pancreas
Fehmann, H. C., Weber, V., Göke, R., Göke, B., & Arnold, R. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80210-a · Cited by 90 · cited 1×
“A role for increased expression and synthesis of IAPP in amyloidogenesis has long been suggested as a likely participating factor due to the tendency for parallel regulation of insulin and IAPP (42,43).”
BackgroundThe microanatomy of the islets of Langerhans.
Orci, L. (1976) · Metabolism: Clinical and Experimental · doi:10.1016/s0026-0495(76)80129-1 · Cited by 84 · cited 1×
“In three dimensions, human islets can be considered as composites of several mantle-core subunits (7) or as lobulated with mantle-core lobules (3).”
Background(1951) · PubMed Central · Cited by 81
Fas-Associated Death Receptor Signaling Evoked by Human Amylin in Islet β-Cells
Zhang, S., Liu, H., Yu, H., & Cooper, G. J. S. (2007) · Diabetes · doi:10.2337/db07-0849 · Cited by 68 · cited 2×
“More recently it was also shown in mouse islets and in two different insulinoma -cell lines that exposure to solutions of hIAPP elicited increased expression and activation of Fas and Fas-associated death domain and led to -cell apoptosis (41).”
BackgroundHuman islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis.
O’Brien, T. D., Butler, P. C., Kreutter, D. K., Kane, L. A., & Eberhardt, N. L. (1995) · Europe PMC (PubMed Central) · Cited by 65
Self-citationThe Pancreatic Polypeptide Cells in the Human Pancreas: The Effects of Age and Diabetes*
Rahier, J., Wallon, J., Loozen, S., LEFEVRE, A., Gepts, W., & Haot, J. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-3-441 · Cited by 62 · cited 2×
“(14) reported mean pancreatic weight from 20 control patients as 85.”
BackgroundTucker, H. M., Rydel, R. E., Wright, S., & Estus, S. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71020506.x · Cited by 59 · cited 1×
“Furthermore, these activities of hIAPP have been linked to induction of apoptosis and, thus, potentially to -cell death in type 2 diabetes (32,33).”
BackgroundNo decrease of the beta-cell mass in type 2 diabetic patients.
Guiot, Y., Sempoux, C. L., Moulin, P., & Rahier, J. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s188 · Cited by 54 · cited 1×
“While several groups have maintained there is no significant decrease in -cell mass in type 2 diabetes (11,14,21,22), most studies have shown a 40–60% decrease, particularly compared with pancreata from nondiabetic individuals of similar body weight or BMI.”
BackgroundStefan, Y., GRASSO, S. G., Perrelet, A., & Orci, L. (1982) · Diabetologia · doi:10.1007/bf01271177 · Cited by 39
O’Brien, T. D., Westermark, P., & Johnson, K. H. (1991) · Diabetes · doi:10.2337/diabetes.40.12.1701 · Cited by 37
Self-citationMitotic figures and enlarged nuclei in the Islands of Langerhans in man.
LeCompte, P. M., & Jc, M. (1962) · PubMed · Cited by 27
Gepts, W., & Veld, P. I. '. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030403 · Cited by 26 · cited 1×
“Fibrosis, particularly along the islet microvasculature, has also been previously reported but has since been found to occur equally in nondiabetic pancreata (9).”
BackgroundCouce, M., Kane, L. A., O’Brien, T. D., Charlesworth, J., Soeller, W. C., McNeish, J. D., Kreutter, D., Roche, P. C., & Butler, P. C. (1996) · Diabetes · doi:10.2337/diabetes.45.8.1094 · Cited by 18
Self-citation
Cited by
Pancreatic islet plasticity: Interspecies comparison of islet architecture and composition
Steiner, D. J., Kim, A., Miller, K., & Hara, M. (2010) · Islets · doi:10.4161/isl.2.3.11815 · Cited by 494
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · Diabetes Care · doi:10.2337/dc14-0396 · Cited by 460
Unique Arrangement of α- and β-Cells in Human Islets of Langerhans
Bosco, D., Armanet, M., Morel, P., Niclauss, N., Sgroi, A., Muller, Y. D., Giovannoni, L., Parnaud, G., & Berney, T. (2010) · Diabetes · doi:10.2337/db09-1177 · Cited by 450
“Our description of human islet cell organization is innovative but does not contradict the different views reported so far about the human islet architecture (6,8,9,11,12), including the diametrically opposed opinions describing islets with either segregated or intermingled cell types.”
BackgroundParacrinology of islets and the paracrinopathy of diabetes
Unger, R. H., & Orci, L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006639107 · Cited by 269
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1425 · Cited by 222
“individuals (55-57), although current data suggest a 20-60% reduction (58).”
Background
Metadata
- Authors
- Bonner-Weir, S., & O'Brien, T. D.
- Affiliations
- Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts
- Department of Veterinary Population Medicine and Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-11-01
- Volume
- 57
- Issue
- 11
- Pages
- 2899-2904
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2570382
- OpenAlex
- W2170188899
- Cited by
- 66
- References
- 52
- Citations by year
- 2024: 1 · 2023: 5 · 2022: 2 · 2021: 1 · 2020: 2 · 2018: 3 · 2017: 1 · 2016: 9 · 2015: 6 · 2014: 8 · 2013: 2 · 2012: 6
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 2 diabetes, pancreatic islets, beta-cell dysfunction, islet architecture, beta cell destruction, insulin resistance, UK Prospective Diabetes Study
- MeSH terms
- Amyloid, Amyloidosis, Diabetes Mellitus, Type 2, Humans, Islets of Langerhans, Biomedical Research, History, 20th Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.